These benefits, together with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 aid the strategy of targeting ACKR3 as a novel method to modulate the opioid procedure, which could open new therapeutic avenues for opioid-linked Ailments. A study study printed in Anesthesiology https://aarone158qhy6.blogunteer.com/profile